117th CONGRESS 2d Session |
To amend the Controlled Substances Act to prohibit the deceptive sale of fentanyl, and for other purposes.
September 28, 2022
Mr. Cotton (for himself, Mr. Cornyn, and Mr. Hawley) introduced the following bill; which was read twice and referred to the Committee on the Judiciary
To amend the Controlled Substances Act to prohibit the deceptive sale of fentanyl, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
This Act may be cited as the “Zero Tolerance for Deceptive Fentanyl Trafficking Act”.
SEC. 2. Prohibition of the deceptive sale of fentanyl.
Section 401 of the Controlled Substances Act (21 U.S.C. 841) is amended by adding at the end the following:
“(i) Deceptive sale of fentanyl and fentanyl-Related substances.—
“(1) OFFENSE.—It shall be unlawful for any person to knowingly misrepresent or knowingly market as another substance a mixture or substance containing fentanyl, a fentanyl analogue, or a fentanyl-related substance (as defined in subsection (e)(2) of schedule I in section 202(c)).
“(A) IN GENERAL.—Except as provided in subparagraph (B), any person who violates paragraph (1) shall be imprisoned for not less than 20 years and fined under title 18, United States Code.
“(i) DEATH RESULTS.—If a violation of paragraph (1) results in death or is committed with the intent to cause death, the person shall be sentenced to death or life imprisonment and fined under title 18, United States Code.
“(ii) PRIOR FELONY CONVICTION OR UNLAWFUL PRESENCE IN THE UNITED STATES.—A person who violates paragraph (1) shall be sentenced to life imprisonment and fined under title 18, United States Code, if the violation occurs—
“(I) after any other prior felony conviction of the person has become final; or
“(II) while the person is unlawfully present in the United States.”.
SEC. 3. Fentanyl-related substances.
Schedule I in section 202(c) of the Controlled Substances Act (21 U.S.C. 812) is amended—
(1) in subsection (b), by adding at the end the following:
“(23) Isobutyryl fentanyl.
“(24) Para-Methoxybutyrylfentanyl.
“(25) Valeryl fentanyl.
“(26) Cyclopentyl fentanyl.
“(27) Para-Chloroisobutyryl fentanyl.”; and
(2) by adding at the end the following:
“(e) (1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a fentanyl-related substance, or which contains the salts, isomers, and salts of isomers of a fentanyl-related substance whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
“(2) For purposes of paragraph (1), the term ‘fentanyl-related substance’ includes the following:
“(A) Any substance that is structurally related to fentanyl by one or more of the following modifications:
“(i) By replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle.
“(ii) By substitution in or on the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino, or nitro groups.
“(iii) By substitution in or on the piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, amino, or nitro groups.
“(iv) By replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle.
“(v) By replacement of the N-propionyl group by another acyl group.
“(B) 4′-Methyl acetyl fentanyl.
“(C) Crotonyl fentanyl.
“(D) 2′-Fluoro ortho-fluorofentanyl.
“(E) Ortho-Methyl acetylfentanyl.
“(F) Thiofuranyl fentanyl.
“(G) Ortho-Fluorobutyryl fentanyl.
“(H) Ortho-Fluoroacryl fentanyl.
“(I) Beta-Methyl fentanyl.
“(J) Phenyl fentanyl.
“(K) Para-Methylfentanyl.
“(L) Beta′-Phenyl fentanyl.
“(M) Benzodioxole fentanyl.”.